Kamyar Kalantar-Zedeh

Title: Kamyar Kalantar-Zedeh: Innovator in Hemodialysis Prognostics

Introduction

Kamyar Kalantar-Zedeh is a notable inventor based in Torrance, CA (US). He has made significant contributions to the field of hemodialysis through his innovative patent. His work focuses on improving patient outcomes by utilizing advanced prognostic methods.

Latest Patents

Kamyar Kalantar-Zedeh holds a patent titled "Prognostic assays for maintenance hemodialysis patients." This patent describes methods for determining the overall survival of maintenance hemodialysis patients. The methods include measuring low-density lipoprotein (LDL) particle size and subfraction concentrations as prognostic tools for early mortality risk detection. For instance, the presence of increased very small LDL concentration or decreased LDL particle size in blood serum serves as a useful means for prognostic risk assessment and monitoring.

Career Highlights

Throughout his career, Kalantar-Zedeh has worked with prominent organizations such as Quest Diagnostics Investments, Inc. and the Los Angeles Biomedical Research Institute. His experience in these institutions has allowed him to develop and refine his innovative approaches to patient care in hemodialysis.

Collaborations

Some of his notable coworkers include Michael P. Caulfield and Wael A. Salameh. Their collaborative efforts have contributed to advancements in the field of hemodialysis and patient prognostics.

Conclusion

Kamyar Kalantar-Zedeh's work in developing prognostic assays for hemodialysis patients exemplifies the impact of innovation in healthcare. His contributions are vital for improving patient survival and monitoring, showcasing the importance of research and development in medical science.